SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-045058
Filing Date
2018-12-12
Accepted
2018-12-12 21:48:01
Documents
2
Period of Report
2018-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6605
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 11709
  Complete submission text file 0001140361-18-045058.txt   20522
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Issuer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022
Business Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 212 593-6900
Avista Acquisition Corp. (Reporting) CIK: 0001661187 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37906 | Film No.: 181232092

Mailing Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022
Business Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 212-593-6900
Avista Acquisition, LLC (Reporting) CIK: 0001686388 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37906 | Film No.: 181232093